MEDICINOVA INC
MediciNova, Inc. is a biopharmaceutical company focused on acquiring and developing novel therapeutics for diseases with unmet medical needs, primarily in the U.S. They focus on neurology, respiratory, and liver diseases. Key products include MN-166 (ibudilast) for neurological disorders, MN-221 for acute exacerbations of asthma, and MN-001 for NASH and fibrotic diseases.
Registro Oficial
Análisis de Calidad IA
Desglose de Puntuación de Confianza
Enlaces Rápidos
Destacados del sitio web
🌟 Empresas similares de confianza
OKYO Pharma Ltd
OKYO Pharma Ltd. (NASDAQ:OKYO) is a biopharmaceutical company dedicated to developing an innovative treatment for neuropathic corneal pain and dry eye disease. Through its proprietary chemerin peptide, OK-101, the company aims to provide targeted therapy that alleviates pain, controls inflammation, and enhances ocular residence time for more effective, lasting relief.
Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new treatments for gastrointestinal (GI) diseases, particularly acid-related disorders. They have licensed exclusive rights in the United States, Europe, and Canada to a potassium-competitive acid blocker (PCAB). Phathom is committed to transforming the treatment landscape and improving the lives of patients.
UroGen Pharma Ltd.
UroGen Pharma is a biopharmaceutical company focused on developing and commercializing innovative treatments for urologic cancers. They utilize RTGel® technology for sustained local delivery of medications to the urinary tract. Their key products include Jelmyto® and Zusduri™, representing advancements in uro-oncology treatment.